Johnston and colleagues [1] found that ketamine potentiates neuromuscular blockade produced by tubocurarine, but not that produced by pancuronium or suxamethonium. The present study was designed to determine the effect on the block produced by atracurium.
1
, fentanyl 7 ng kg" 1 and atropine 0.5 mg i.v., and maintained with fentanyl and 66% nitrous oxide in oxygen.
The ulnar nerve was stimulated supramaximally at the wrist through surface electrodes, and the force of contraction of the adductor pollicis was recorded using a force-displacement transducer (TD 100, Biometer, Denmark), with a resting load of 200-300 g. The stimuli applied were square waves of 0.2 ms duration, at 0.1 Hz (Myotest, Biometer, Denmark). The output of the transducer was recorded on a Myograph 2000 (Biometer, Denmark). Following a period of at least 10 min to allow stabilization of the twitch response, the patients in the ketamine group received ketamine 2 mg kg" 1 i.v. followed by an infusion of 2 mg kg" 1 h" 1 . Atracurium 0.5 mg kg" was injected i.v. 2 min after the ketamine bolus dose, and the duration of neuromuscular blockade was measured from the end of injection until the twitch height had recovered to 25 % of the control twitch height obtained at the end of the stabilization period.
SUMMARY
Ventilation was controlled at all times, and adjusted to maintain the end-tidal carbon dioxide partial pressure at 5.0-5.5 kPa (Normocap, Datex).
Systemic arterial pressure was recorded every 5 min and central (upper oesophagus) and peripheral (thenar eminence) temperatures were monitored continuously (TR 9, Ellab, Denmark).
Mann-Whitney U tests were used for statistical analysis between groups. Probability values <0.05 were considered statistically significant.
Three patients in each group were withdrawn from the study because of various technical problems during the period of stabilization of the twitch response. The remaining two groups of 20 patients were similar with respect to age, weight and height.
The median (and 1st and 3rd quartile) duration of neuromuscular blockade was 38. The 95% confidence interval was from 2.3 to 11.8min. There were no differences between the groups with respect to arterial pressures, and central and peripheral temperatures.
In the period between injection of atracurium and 25 % recovery of the twitch response, eight patients in the control group and two patients in the ketamine group needed supplementary fentanyl 0.1-0.3 mg (0.05 < P < 0.1).
effect of all neuromuscular blocking drugs, but results from in vivo studies are inconclusive. In one study, ketamine potentiated the effect of suxamethonium, but not that of pancuronium and tubocurarine [5] , while in another, ketamine potentiated the effect of tubocurarine, but not those of pancuronium or suxamethonium [1] .
The groups in the present study were comparable regarding central temperature, peripheral temperature and arterial pressure. There was a slight, but not statistically significant difference between the groups with respect to the supplementary dose of fentanyl. It is unlikely that this would affect the duration of neuromuscular blockade [6] . Because of the large individual variability in sensitivity to non-depolarizing neuromuscular blocking agents, the clinical implication of the 21 % increase in the duration of neuromuscular blockade is limited, but does emphasize the need for more frequent use of monitoring of neuromuscular transmission. It remains to be established if ketamine affects the duration of neuromuscular blockade induced by other neuromuscular blocking drugs, and if it affects neuromuscular transmission when the margin of safety is otherwise reduced.
